Postexposure prophylaxis following HIV exposure

JAMA. 1999 Apr 14;281(14):1269-70.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-HIV Agents / economics*
  • Anti-HIV Agents / therapeutic use
  • Cost-Benefit Analysis
  • HIV Infections / economics
  • HIV Infections / prevention & control*
  • Humans
  • Insurance, Health
  • Policy Making
  • Preventive Medicine / economics
  • United States

Substances

  • Anti-HIV Agents